Microglia, a new cellular factor, in the development of hypertension (875.6)

you li,liang li,kenneth e bernstein,xiao shen,peng shi
DOI: https://doi.org/10.1096/fasebj.28.1_supplement.875.6
2014-01-01
The FASEB Journal
Abstract:The concept of neuroinflammation in the development of hypertension has been acknowledged recently, as studies showed that anti‐inflammation treatments attenuated Ang II induced blood pressure increase. Microglia are the major immune cells in the central nervous system. To examine the role of microglia in hypertension, we applied a microglial depletion strategy by using a transgenic mouse line CD11b‐DTR. This mouse line has an inserted transgene coding simian diphtheria toxin receptor (DTR) under the control of the CD11b promoter. CD11b‐DTR mice were made hypertensive by subcutaneous Ang II infusion. Two weeks later, the mice received intracerebroventricular infusion of either DT or saline. Blood pressure was monitored by tailcuff. It showed that systolic blood pressure reached ~140 mmHg in both groups by 2 wk. Microglial depletion caused a gradual reduction in blood pressure (20 mmHg) by the end of 4 wk. To validate the importance of microglia in neuroinflammation associated with hypertension, the expression of pro‐inflammatory cytokines in paraventricular nucleus (PVN) were analyzed by quantative RT‐PCR. Microglial depletion reduced the expression of both IL‐1β and TNFα in the PVN of hypertensive mice. Moreover, the norepinephrine levels in the kidney were significantly decreased in the microglia‐depleted mice vs. controls. These data strongly support our hypothesis that in hypertension, microglia play an importance role in initiating neuroinflammation and in sustaining blood pressure. Grant Funding Source : AHA and UCLA CTSI
What problem does this paper attempt to address?